Search results
Results from the WOW.Com Content Network
Lithium toxicity, also known as lithium overdose, is the condition of having too much lithium. Symptoms may include a tremor, increased reflexes, trouble walking, kidney problems, and an altered level of consciousness .
Lithium toxicity, which is also called lithium overdose and lithium poisoning, is the condition of having too much lithium in the blood. This condition also happens in persons who are taking lithium in which the lithium levels are affected by drug interactions in the body.
This is the list of extremely hazardous substances defined in Section 302 of the U.S. Emergency Planning and Community Right-to-Know Act (42 U.S.C. § 11002). The list can be found as an appendix to 40 CFR 355. [1] Updates as of 2006 can be seen on the Federal Register, 71 FR 47121 (August 16, 2006). [2]
Lithium-ion batteries (including lithium-ion polymer batteries) UN 3481: 9: Lithium-ion batteries contained in equipment or lithium-ion batteries packed with equipment (including lithium-ion polymer batteries) UN 3482: 4.3: Alkali metal dispersion, flammable or alkaline earth metal dispersion, flammable UN 3483: 6.1: Motor fuel anti-knock ...
Lithium hydroxide and lithium peroxide are the salts most commonly used in confined areas, such as aboard spacecraft and submarines, for carbon dioxide removal and air purification. Lithium hydroxide absorbs carbon dioxide from the air by forming lithium carbonate, and is preferred over other alkaline hydroxides for its low weight.
Any material that meets the definition in 49 CFR 171.8 for an elevated temperature material, a hazardous substance, a hazardous waste, or a marine pollutant. A new sub-class, class 9A, has been in effect since January 1, 2017. This is limited to the labeling of the transport of lithium batteries.
The WHODrug Dictionary is an international classification of medicines created by the WHO Programme for International Drug Monitoring and managed by the Uppsala Monitoring Centre. [ 1 ] It is used by pharmaceutical companies , clinical trial organizations and drug regulatory authorities for identifying drug names in spontaneous ADR reporting ...
Genotoxicity might involve carcinogenicity, the ability to cause cancer in animal models, humans or both; teratogenicity, which is the ability to cause defects on fetal development or fetal malformation; and lastly hazardous drugs are known to have the potential to cause fertility impairment, which is a major concern for most clinicians. [1]